NCT05219500 2026-04-03
TATCIST
Fusion Pharmaceuticals Inc.
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT04869488 2025-01-24
A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT03454750 2025-01-08
LU-PSMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Completed
NCT03042312 2021-03-24
RESIST-PC
Endocyte
Phase 2 Terminated